43/120
1.8 / 5 stars
All 120 Win/Lose results shown below
PRPO Roast Me summary
Precipio, Inc. (PRPO). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LosePRPO / S&P -0.96% / 15.20% |
WinPRPO / S&P 28.04% / 15.00% |
LosePRPO / S&P PRPO unavailable / 50.40% |
| 2026-Q12/3 |
WinPRPO / S&P 8.79% / -4.33% |
WinPRPO / S&P 28.97% / 11.30% |
LosePRPO / S&P PRPO unavailable / 27.70% |
| 2025-Q42/3 |
WinPRPO / S&P 29.17% / 2.65% |
WinPRPO / S&P 29.77% / 9.00% |
LosePRPO / S&P PRPO unavailable / 13.40% |
| 2025-Q32/3 |
WinPRPO / S&P 61.14% / 8.12% |
WinPRPO / S&P 30.95% / 4.61% |
LosePRPO / S&P PRPO unavailable / 13.45% |
| 2025-Q22/3 |
WinPRPO / S&P 76.08% / 10.94% |
WinPRPO / S&P 27.05% / 4.83% |
LosePRPO / S&P PRPO unavailable / 10.63% |
| 2025-Q12/3 |
WinPRPO / S&P 13.18% / -4.27% |
WinPRPO / S&P 26.67% / 4.98% |
LosePRPO / S&P PRPO unavailable / 10.57% |
| 2024-Q41/3 |
LosePRPO / S&P -17.31% / 2.41% |
WinPRPO / S&P 21.95% / 5.25% |
LosePRPO / S&P PRPO unavailable / 6.15% |
| 2024-Q32/3 |
WinPRPO / S&P 29.09% / 5.89% |
WinPRPO / S&P 31.31% / 5.89% |
LosePRPO / S&P PRPO unavailable / 6.11% |
| 2024-Q21/3 |
LosePRPO / S&P -22.54% / 4.28% |
WinPRPO / S&P 52.61% / 5.38% |
LosePRPO / S&P PRPO unavailable / 5.12% |
| 2024-Q11/3 |
LosePRPO / S&P 3.08% / 10.56% |
WinPRPO / S&P 61.64% / 5.71% |
LosePRPO / S&P PRPO unavailable / 5.59% |
| 2023-Q42/3 |
WinPRPO / S&P 15.86% / 11.69% |
WinPRPO / S&P 61.46% / 6.81% |
LosePRPO / S&P PRPO unavailable / 7.78% |
| 2023-Q31/3 |
LosePRPO / S&P -28.08% / -3.27% |
WinPRPO / S&P 40.22% / 7.52% |
LosePRPO / S&P PRPO unavailable / -5.03% |
| 2023-Q21/3 |
LosePRPO / S&P -41.27% / 8.74% |
WinPRPO / S&P 15.48% / 9.50% |
LosePRPO / S&P PRPO unavailable / -8.57% |
| 2023-Q11/3 |
WinPRPO / S&P 20.51% / 7.50% |
LosePRPO / S&P 3.27% / 10.77% |
LosePRPO / S&P PRPO unavailable / -15.69% |
| 2022-Q40/3 |
LosePRPO / S&P -31.47% / 7.56% |
LosePRPO / S&P 6.36% / 11.88% |
LosePRPO / S&P PRPO unavailable / -17.99% |
| 2022-Q30/3 |
LosePRPO / S&P -24.15% / -4.88% |
LosePRPO / S&P 13.18% / 13.47% |
LosePRPO / S&P PRPO unavailable / -1.41% |
| 2022-Q21/3 |
LosePRPO / S&P -21.48% / -16.10% |
WinPRPO / S&P 22.63% / 13.71% |
LosePRPO / S&P PRPO unavailable / 11.04% |
| 2022-Q11/3 |
LosePRPO / S&P -14.56% / -4.60% |
WinPRPO / S&P 41.37% / 15.97% |
LosePRPO / S&P PRPO unavailable / 42.23% |
| 2021-Q41/3 |
LosePRPO / S&P -43.97% / 11.03% |
WinPRPO / S&P 45.26% / 15.00% |
LosePRPO / S&P PRPO unavailable / 96.40% |
| 2021-Q31/3 |
LosePRPO / S&P -22.31% / 0.58% |
WinPRPO / S&P 72.66% / 10.77% |
LosePRPO / S&P PRPO unavailable / 69.42% |
| 2021-Q22/3 |
WinPRPO / S&P 57.14% / 8.55% |
WinPRPO / S&P 93.59% / 6.58% |
LosePRPO / S&P PRPO unavailable / 51.81% |
| 2021-Q12/3 |
WinPRPO / S&P 11.59% / 6.17% |
WinPRPO / S&P 84.57% / -1.06% |
LosePRPO / S&P PRPO unavailable / 7.39% |
| 2020-Q41/3 |
LosePRPO / S&P -15.51% / 12.15% |
WinPRPO / S&P 94.82% / -3.72% |
LosePRPO / S&P PRPO unavailable / -33.42% |
| 2020-Q32/3 |
WinPRPO / S&P 72.54% / 8.93% |
WinPRPO / S&P 54.90% / -2.04% |
LosePRPO / S&P PRPO unavailable / -27.10% |
| 2020-Q22/3 |
WinPRPO / S&P 102.86% / 20.54% |
WinPRPO / S&P 33.65% / -0.46% |
LosePRPO / S&P PRPO unavailable / -27.11% |
| 2020-Q11/3 |
LosePRPO / S&P -65.85% / -19.60% |
WinPRPO / S&P 26.70% / 3.47% |
LosePRPO / S&P PRPO unavailable / -14.75% |
| 2019-Q41/3 |
LosePRPO / S&P -21.46% / 9.07% |
WinPRPO / S&P 9.18% / 5.36% |
LosePRPO / S&P PRPO unavailable / 2.99% |
| 2019-Q30/3 |
LosePRPO / S&P -22.78% / 1.70% |
LosePRPO / S&P 0.00% / 5.02% |
LosePRPO / S&P PRPO unavailable / 0.21% |
| 2019-Q22/3 |
WinPRPO / S&P 80.27% / 4.30% |
WinPRPO / S&P 8.97% / 6.64% |
LosePRPO / S&P PRPO unavailable / 8.65% |
| 2019-Q11/3 |
LosePRPO / S&P -18.83% / 13.65% |
WinPRPO / S&P 31.00% / 8.12% |
LosePRPO / S&P PRPO unavailable / 14.29% |
| 2018-Q41/3 |
LosePRPO / S&P -61.01% / -13.52% |
WinPRPO / S&P 66.22% / 9.05% |
LosePRPO / S&P PRPO unavailable / 18.23% |
| 2018-Q31/3 |
LosePRPO / S&P 7.34% / 7.71% |
WinPRPO / S&P 297.96% / 10.21% |
LosePRPO / S&P PRPO unavailable / 19.06% |
| 2018-Q21/3 |
LosePRPO / S&P -31.47% / 3.43% |
WinPRPO / S&P 185.83% / 9.03% |
LosePRPO / S&P PRPO unavailable / 14.46% |
| 2018-Q11/3 |
LosePRPO / S&P -55.25% / -0.76% |
WinPRPO / S&P 66.31% / 7.68% |
LosePRPO / S&P PRPO unavailable / 12.46% |
| 2017-Q40/3 |
LosePRPO / S&P -44.44% / 6.64% |
LosePRPO / S&P 0.00% / 7.03% |
LosePRPO / S&P PRPO unavailable / 13.82% |
| 2017-Q30/3 |
LosePRPO / S&P -76.00% / 4.48% |
LosePRPO / S&P PRPO unavailable / 5.68% |
LosePRPO / S&P PRPO unavailable / 17.57% |
| 2017-Q20/3 |
LosePRPO / S&P PRPO unavailable / 3.09% |
LosePRPO / S&P PRPO unavailable / 4.83% |
LosePRPO / S&P PRPO unavailable / 17.74% |
| 2017-Q10/3 |
LosePRPO / S&P PRPO unavailable / 6.07% |
LosePRPO / S&P PRPO unavailable / 3.67% |
LosePRPO / S&P PRPO unavailable / 13.32% |
| 2016-Q40/3 |
LosePRPO / S&P PRPO unavailable / 3.82% |
LosePRPO / S&P PRPO unavailable / 2.09% |
LosePRPO / S&P PRPO unavailable / 7.05% |
| 2016-Q30/3 |
LosePRPO / S&P PRPO unavailable / 3.85% |
LosePRPO / S&P PRPO unavailable / 0.20% |
LosePRPO / S&P PRPO unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | PRPO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 83.25% | 20.78% |
| Annualized return | 83.25% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | PRPO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -57.04% | 83.14% |
| Annualized return | -15.55% | 12.86% |
10Y · 2017-06-30 to 2026-08-28
| Metric | PRPO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.95% | 319.30% |
| Annualized return | -36.58% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |